Health Care: Drugs

Allergan PLC (AGN: NYSE)

$185.3499 -5.5901 | -2.93%
12/07/16 - 09:51 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 15.07B 6.74B 2.60B 5.91B
Cost of Sales 2.67B 1.57B 466.50M 3.19B
Gross Operating Profit 12.40B 5.17B 2.14B 2.72B
Selling, General, and Administrative Expenses 4.68B 2.45B 830.90M 1.17B
Research & Development 2.36B 605.70M 191.30M 402.50M
Operating Income before D & A (EBITDA) 5.36B 2.12B 1.11B 1.15B
Depreciation & Amortization 7.60B 3.83B 1.48B 684.80M
Interest Income 11.40M 8.90M 4.80M 2.50M
Other Income - Net -233.80M -27.30M -18.60M -10.00M
Special Income / Charges -783.60M -730.00M -1.00M -101.00M
Total Income Before Interest Expenses (EBIT) -3.24B -2.46B -383.00M 356.70M
Interest Expense 1.19B 411.80M 239.80M 111.60M
Pre-Tax Income -4.43B -2.87B -622.80M 245.10M
Income Taxes -1.56B -467.00M -155.30M 146.80M
Minority Interest 4.20M 0.00 0.00 1.00M
Net Income From Continuing Operations -2.87B -2.41B -467.50M 98.30M
Net Income From Discontinued Operations 6.79B 776.60M -282.90M 0.00
Net Income From Total Operations 3.92B -1.63B -750.40M 98.30M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 3.92B -1.63B -750.40M 97.30M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.08B -1.68B -466.50M 199.30M
Preferred Dividends
Net Income Available To Common -3.10B -2.41B -467.50M 98.30M
Basic EPS from Continuing Ops. -8.44 -10.96 -3.29 0.77
Basic EPS from Discontinued Ops. 18.45 3.54 -1.98 0.00
Basic EPS from Total Operations 10.01 -7.42 -5.27 0.77
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 10.01 -7.42 -5.27 0.77
Basic Normalized Net Income/Share -6.13 -7.64 -3.28 1.56
EPS fr Continuing Ops. -8.44 -10.96 -3.29 0.76
EPS fr Discontinued Ops 18.45 3.54 -1.98 0.00
EPS fr Total Ops. 10.01 -7.42 -5.27 0.76
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 10.01 -7.42 -5.27 0.76
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-6.13 -7.64 -3.28 1.54
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter